GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 98 filers reported holding GOSSAMER BIO INC in Q1 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,803,929 | +95.4% | 2,165,579 | +181.6% | 0.00% | – |
Q2 2023 | $922,990 | -45.6% | 769,159 | -42.9% | 0.00% | – |
Q1 2023 | $1,696,286 | +60266.0% | 1,346,259 | +3.9% | 0.00% | – |
Q4 2022 | $2,810 | -100.0% | 1,295,114 | +2.9% | 0.00% | -100.0% |
Q3 2022 | $15,080,000 | +75.6% | 1,258,769 | +22.7% | 0.00% | +100.0% |
Q2 2022 | $8,588,000 | -3.9% | 1,026,055 | -0.4% | 0.00% | 0.0% |
Q1 2022 | $8,938,000 | -22.0% | 1,029,827 | +1.7% | 0.00% | 0.0% |
Q4 2021 | $11,457,000 | -8.5% | 1,013,083 | +1.7% | 0.00% | -50.0% |
Q3 2021 | $12,516,000 | +67.1% | 995,761 | +8.0% | 0.00% | +100.0% |
Q2 2021 | $7,489,000 | -4.2% | 922,294 | +9.1% | 0.00% | 0.0% |
Q1 2021 | $7,821,000 | +4.1% | 845,594 | +8.8% | 0.00% | 0.0% |
Q4 2020 | $7,513,000 | -23.2% | 776,997 | -1.5% | 0.00% | -50.0% |
Q3 2020 | $9,787,000 | +0.2% | 788,707 | +4.9% | 0.00% | 0.0% |
Q2 2020 | $9,770,000 | +62.7% | 751,578 | +27.0% | 0.00% | 0.0% |
Q1 2020 | $6,004,000 | -63.6% | 591,596 | -43.9% | 0.00% | 0.0% |
Q4 2019 | $16,486,000 | +96.4% | 1,054,810 | +110.9% | 0.00% | 0.0% |
Q3 2019 | $8,396,000 | +55.8% | 500,095 | +105.8% | 0.00% | +100.0% |
Q2 2019 | $5,389,000 | +19.6% | 242,989 | +16.8% | 0.00% | 0.0% |
Q1 2019 | $4,507,000 | – | 207,997 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |